ST. LOUIS - Results of a Phase III clinical study using botulinum toxin type A to treat primary axillary hyperhidrosis, or excessive underarm sweating, show that botulinum toxin type A is safe and ...

NEW YORK, March 18, 2023 /PRNewswire/ -- Aquavit Holdings has submitted to FDA an IND for its DTX-024, for the treatment of palmar hyperhidrosis using its patented microchannel technology™. DTX-024 is ...

(HealthDay News) — For patients with hyperhidrosis, botulinum toxin treatment is associated with significant improvements in mental and physical health, according to a study published online Feb. 15 ...

- This is the Company's second granted patent for DMT410, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis - - The Company recently entered into a Clinical Trial ...

Treatment of hyperhidrosis can be divided into topical, oral, surgical, and nonsurgical treatments (botulinum toxin). These therapeutic options differ with respect to their efficacy, duration of ...

Women are at higher risk of hyperthyroidism than men, although both sexes can be affected, with risk greatest in patients with a family history of Graves disease or other thyroid disorders. 7 In ...

Botulinum toxin (BoNT), often referred to as a “miracle poison,” is one of the deadliest biological substances known to man. 1 BoNT is a neurotoxin produced by Clostridium botulinum. A rod-shaped ...

Are there any effective treatments for hyperhidrosis? — Gerardo M. Maradiaga, MD, Roanoke Rapids, N.C. Hyperhidrosis is estimated to affect 1%-2% of the U.S. population and can create problems for ...

The Business Research Company's Palmar Hyperhidrosis Treatment Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 Save 30% On All Global Market Reports With Code ONLINE30 – Stay ...